Androgen receptor pathway inhibitor combination in prostate cancer

被引：0
|
作者：
Kelvin Yan
机构：
[1] Royal Marsden Hospital,
来源：
Nature Reviews Urology | 2022年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 627
相关论文
共 50 条
  • [21] Androgen receptor in prostate cancer
    Heinlein, CA
    Chang, CS
    [J]. ENDOCRINE REVIEWS, 2004, 25 (02) : 276 - 308
  • [22] Androgen receptor and prostate cancer
    E Richter
    S Srivastava
    A Dobi
    [J]. Prostate Cancer and Prostatic Diseases, 2007, 10 : 114 - 118
  • [23] The androgen/androgen receptor axis in prostate cancer
    Bluemn, Eric G.
    Nelson, Peter S.
    [J]. CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 251 - 257
  • [24] Darolutamide as a Second-Generation Androgen Receptor Inhibitor in the Treatment of Prostate Cancer
    Abbasi, Ali
    Movahedpour, Ahmad
    Amiri, Ahmad
    Najaf, Mohamad Samare
    Mostafavi-Pour, Zohreh
    [J]. CURRENT MOLECULAR MEDICINE, 2021, 21 (04) : 332 - 346
  • [25] ARN-509 Androgen receptor signaling inhibitor Prostate cancer therapy
    Reviriego, C.
    [J]. DRUGS OF THE FUTURE, 2015, 40 (02) : 101 - 108
  • [26] Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
    Aurilio, Gaetano
    Cimadamore, Alessia
    Mazzucchelli, Roberta
    Lopez-Beltran, Antonio
    Verri, Elena
    Scarpelli, Marina
    Massari, Francesco
    Cheng, Liang
    Santoni, Matteo
    Montironi, Rodolfo
    [J]. CELLS, 2020, 9 (12) : 1 - 14
  • [27] Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
    Mohammad Asim
    Firas Tarish
    Heather I. Zecchini
    Kumar Sanjiv
    Eleni Gelali
    Charles E. Massie
    Ajoeb Baridi
    Anne Y. Warren
    Wanfeng Zhao
    Christoph Ogris
    Leigh-Anne McDuffus
    Patrice Mascalchi
    Greg Shaw
    Harveer Dev
    Karan Wadhwa
    Paul Wijnhoven
    Josep V. Forment
    Scott R. Lyons
    Andy G. Lynch
    Cormac O’Neill
    Vincent R. Zecchini
    Paul S. Rennie
    Aria Baniahmad
    Simon Tavaré
    Ian G. Mills
    Yaron Galanty
    Nicola Crosetto
    Niklas Schultz
    David Neal
    Thomas Helleday
    [J]. Nature Communications, 8
  • [28] Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
    Asim, Mohammad
    Tarish, Firas
    Zecchini, Heather I.
    Sanjiv, Kumar
    Gelali, Eleni
    Massie, Charles E.
    Baridi, Ajoeb
    Warren, Anne Y.
    Zhao, Wanfeng
    Ogris, Christoph
    McDuffus, Leigh-Anne
    Mascalchi, Patrice
    Shaw, Greg
    Dev, Harveer
    Wadhwa, Karan
    Wijnhoven, Paul
    Forment, Josep V.
    Lyons, Scott R.
    Lynch, Andy G.
    O'Neill, Cormac
    Zecchini, Vincent R.
    Rennie, Paul S.
    Baniahmad, Aria
    Tavare, Simon
    Mills, Ian G.
    Galanty, Yaron
    Crosetto, Nicola
    Schultz, Niklas
    Neal, David
    Helleday, Thomas
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [29] Targeting the FGFR pathway in androgen receptor negative castration resistant prostate cancer
    Morrissey, Colm
    Corey, Eva
    Brown, Lisha
    Coleman, Ilsa
    Nguyen, Holly
    Schweizer, Michael
    Nelson, Peter
    [J]. CANCER RESEARCH, 2017, 77
  • [30] Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
    Obinata, Daisuke
    Lawrence, Mitchell G.
    Takayama, Kenichi
    Choo, Nicholas
    Risbridger, Gail P.
    Takahashi, Satoru
    Inoue, Satoshi
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
12345